3D Medical Imaging Devices Market Outlook (Revenue, USD Million; 2014 - 2025)
3D medical imaging devices industry can be classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe tracked North America, and both jointly were responsible for above 60% share of the market in 2017. The development of the North American region is credited to the greater procuring power of the healthcare centers, for example, advanced specialty centers, hospitals, and centers of extended duration care. Furthermore, well-established infrastructure of healthcare as equated to emerging areas together with an advantageous setup of compensation is expected to boost the regional development for the duration of the forecast.
Download Free Sample - https://www.millioninsights.com/industry-reports/3d-medical-imaging-devices-market/request-sample
The Asia Pacific is projected to show substantial development by the completion of 2026. It is motivated by refining the infrastructure of healthcare and increasing medicinal tourism. Yet, the greater prices of 3D medical imaging devices and a small proportion of implementation are some of the reasons obstructing the development of the local market.
Latest developments for example 3D spinal imaging presented by the Toshiba group has propelled clinics to make a diagnosis of some irregularity in the spinal area. This has overwhelmed the need for extra dosage for conventional 3D medical imaging.
Some of the important companies for the 3D medical imaging devices market are Del Medical Systems Inc., Shimadzu Corporation, Canon Medical Systems, Koninklijke Philips N.V., DigiRad Corporation, and Esaote SpA. Additional notable companies are Samsung Medison, GE Health Care Ltd., The Esaote Group, Siemens Healthcare, Barco NV, Toshiba America Medical Systems, Hitachi Aloka Medical, and Tom Tec Imaging Systems GmbH.
Comments
Post a Comment